Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries.
about
The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?Management of mantle cell lymphoma in the elderly patientHematopoietic cell transplantation for B-cell lymphoma: an updateAllogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older PatientsOutcomes of both abbreviated hyper-CVAD induction followed by autologous hematopoietic cell transplantation and conventional chemotherapy for mantle cell lymphoma: a 10-year single-centre experience with literature reviewMantle cell lymphoma: observation to transplantationEvaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS groupMantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches.Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup studyMature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation.Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study.Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.Treatment of mantle cell lymphoma: targeting the microenvironment.Stem cell transplantation for mantle cell lymphoma: if, when and how?Autografting followed by rituximab for chemosensitive mantle cell lymphoma: a pilot study and literature review.Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network.Long-Term Results of Fludarabine/Melphalan as a Reduced-Intensity Conditioning Regimen in Mantle Cell Lymphoma: The GELTAMO Experience.Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant researchNon-Hodgkin's lymphomas, version 4.2014.Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen.Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL.Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab eraTherapeutic options in mantle cell lymphoma.Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma.Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modalityMantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?Autologous and allogeneic stem cell transplantation: rising therapeutic promise for mantle cell lymphoma.Controversies in the treatment of lymphoma with autologous transplantation.Autologous stem cell transplantation for mantle cell lymphoma - single centre experience.Hematopoietic SCT for mantle cell lymphoma: is it the standard of care?Transplantation for non-Hodgkin lymphoma.Hematopoietic cell transplantation for lymphomas.Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant?Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era?Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group.Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation.The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma.
P2860
Q26772907-59DB0054-C5A0-4C64-B347-A7EBDBCB805DQ26999395-C8D23922-49E5-4DD0-B963-C9F1A03806DEQ27026617-800DADB6-B4D0-47FD-A917-0BF5E4D92457Q28066710-BB50C5E1-ED22-4CD2-B9BF-175F9D78FFEEQ28087748-72662BC2-A240-410A-B4F6-A83C3A2805E6Q28256317-E01CBA62-3A03-447D-AE84-E396F30B70B3Q33388563-4BA842BD-5422-46C1-A1E4-8F52CC3E1924Q33586239-1C50DB16-FB22-4422-BD24-8CE09C99F5F9Q34095473-D11FEF63-D8CC-4AB8-B8EB-4E2DD65B65FCQ34603567-726AA040-24CE-41C4-B16F-33EEE6981D86Q35170208-92D75F0F-8829-4B28-A344-9B2399BE4A8CQ36117384-E72FA496-AE29-4537-B6B7-0D37CC6CA158Q36117647-91E76ECB-914D-4DCA-833D-63461334A073Q36185624-FE906026-889C-44ED-8C11-E45787C725DFQ36188687-C21C7F81-416A-4AC2-BD30-5EDF09CF13ADQ36194673-2686308E-9980-4058-AF81-BF482F079282Q36371815-5D70535D-B07F-449A-B40A-5BF84F9D560FQ36612548-FF1CDD1C-80C4-4919-AA3A-C132B09F98D0Q36806876-CA481634-EE9F-42BC-9172-5A5C529DBDDAQ36820885-4CA72437-EDE5-4CF0-8DBE-8A588B0D063DQ36837797-D3C95242-8196-4A08-A190-E96E90F99581Q37015682-D7446410-DD81-4B32-AE6B-5F4BDAB5ABEEQ37071972-125D3602-E136-44D4-8FCE-D04BA7B5366CQ37093669-84E342AB-12D9-4442-BC66-C0C2044F8FC3Q37356389-333E9895-6D97-4DAF-AAF7-717F92378617Q37402853-64726725-2C20-40B3-BA9E-4DD7A66052D8Q37474352-2F22B4F4-B07F-48E9-AA9A-7E4B4B8AE54BQ37498829-B0C1EBCF-86B2-4646-9D5F-F3266F686096Q37534534-BF69692F-307F-4B59-9127-F524BEC5BA47Q37534547-5F4A4E4A-31A6-444E-95F0-810896156942Q37593800-DF47ED23-C914-4E2B-811B-D70AA1356F8EQ37601871-32203331-3550-4C3C-9858-B698701738B4Q37728866-0DC15D47-5D15-45EE-8795-BB86246EBBCCQ37810079-FE63855E-93E0-433F-B392-B5DB308B6775Q37942817-5278F78C-7C44-4110-B13F-753BFDBE96D0Q38045706-80162D6D-3CBC-45A6-9CF4-FF12AD688721Q38098877-43E51670-1929-4B13-AF83-5475BF34006FQ38110232-BA9033B6-9C14-445C-B001-1F004A328914Q38160456-C2C262C3-BA9B-4229-A6AB-FAF7A9E84A8CQ38230693-48FA4D8D-0108-4578-9E00-D2290A997123
P2860
Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Outcome of autologous transpla ...... Marrow Transplant Registries.
@ast
Outcome of autologous transpla ...... Marrow Transplant Registries.
@en
type
label
Outcome of autologous transpla ...... Marrow Transplant Registries.
@ast
Outcome of autologous transpla ...... Marrow Transplant Registries.
@en
prefLabel
Outcome of autologous transpla ...... Marrow Transplant Registries.
@ast
Outcome of autologous transpla ...... Marrow Transplant Registries.
@en
P2093
P50
P1476
Outcome of autologous transpla ...... Marrow Transplant Registries.
@en
P2093
A López-Guillermo
Anthony H Goldstone
C Gisselbrecht
Carmen Ruiz de Elvira
Dennis D Weisenburger
Fausto R Loberiza
J Douglas Rizzo
Koen van Biesen
Mary M Horowitz
P2860
P304
P356
10.1046/J.1365-2141.2003.04140.X
P407
P577
2003-03-01T00:00:00Z